Proponents say the waiver would free innovators in other countries to pursue their own coronavirus vaccines, without fear of patent infringement lawsuits
For decades, the Gateses have been powerful forces on the world stage, their vast charitable contributions affording them access to the highest levels of government, business and the nonprofit sector
Unlike rival Citibank, Standard Chartered Bank has the option to explore retail banking more aggressively. Backed by a digital thrust, CEO Zarin Daruwala has more opportunities than challenges ahead of her
The growing distress across India has tarnished Modi's aura of political invulnerability, which he won by steamrolling the opposition and leveraging his personal charisma to become India's most powerful politician in decades
Some 17 million people from India were living outside their homeland in 2020, according to figures from the United Nations, and millions more have Indian heritage, making the diaspora the largest in the world
For a startup that spent its first four years figuring out a growth path, it took clarity, customer focus, and a leap of faith to make it big in the global market
Tech Mahindra's MD & CEO opens up about his childhood, his parents and grandparents, his love for road trips, and a lot more in the season finale of Forbes India Beyond the Boardroom
Beijing made it abundantly clear late last year that it was serious about curbing the power of a handful of companies that dominate online life in China
In 2018, Sheikha Latifa, the daughter of Dubai's ruler Sheikh Mohammed bin Rashid Al Maktoum, fled Dubai in a yacht but was turned over to Emirati security officers by Indian commandos who had raided the boat and seized her
Some of the most fascinating topics covered this week are: Management (Why smart people make bad decisions), Society (Two worlds in which we live), Technology (A brief history of Bitcoin), Capitalism (Playing boardgames right), Strategy (The illusion of certainty), and Investing (The retirement fund time bomb).
States have struck deals with companies to procure doses but with no clarity on supply chain and delivery, inoculations likely to be delayed by at least a week to 10 days